{
    "organizations": [],
    "uuid": "a9f5c04009ee025312cf881d61db2540fe426768",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cspc-pharmaceutical-groups-drug-ge/brief-cspc-pharmaceutical-groups-drug-gets-approval-by-china-fda-idUSFWN1RP0F8",
    "ord_in_thread": 0,
    "title": "BRIEF-CSPC Pharmaceutical Group's Drug Gets Approval By China FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - CSPC Pharmaceutical Group Ltd :\n* GRANTED APPROVAL BY CHINA FDA FOR PASSING CONSISTENCY OF QUALITY AND EFFICACY EVALUATION OF GENERIC DRUGS\n* APPROVAL FOR GROUP’S DRUG “WEIHONG” Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-12T17:54:00.000+03:00",
    "crawled": "2018-04-13T17:38:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cspc",
        "pharmaceutical",
        "group",
        "ltd",
        "granted",
        "approval",
        "china",
        "fda",
        "passing",
        "consistency",
        "quality",
        "efficacy",
        "evaluation",
        "generic",
        "drug",
        "approval",
        "group",
        "drug",
        "weihong",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}